Table 1.

Characteristics of 470 Hodgkin lymphoma cases diagnosed between 1999 and 2002 and examined for serum YKL-40 and IL-6

StratumTreatment status (n)
AllPre-onsetAfter onsetUnknown
Total470 (100%)176 (100%)196 (100%)98 (100%)
Country of residence
    Sweden288 (61%)121 (69%)109 (56%)58 (59%)
    Denmark182 (39%)55 (31%)87 (44%)40 (41%)
Sex
    Male245 (48%)102 (48%)94 (48%)49 (50%)
    Female225 (52%)74 (52%)102 (52%)49 (50%)
Age [y; median (25-75%)]35 (27-54)35 (27-54)35 (26-54)38 (29-54)
HL histology
    Nodular sclerosis326 (69%)116 (66%)148 (75%)62 (63%)
    Mixed cellularity86 (18%)37 (21%)31 (16%)18 (18%)
    Other/undefined58 (12%)23 (13%)17 (9%)18 (18%)
HL stage (Ann Arbor)
    I74 (16%)32 (18%)34 (17%)8 (8%)
    II187 (40%)82 (47%)74 (38%)31 (32%)
    III84 (18%)34 (19%)40 (20%)10 (10%)
    IV43 (9%)18 (10%)16 (8%)9 (9%)
    Missing82 (18%)10 (6%)32 (16%)40 (41%)
  • Abbreviation: HL, Hodgkin lymphoma.